Discrimination and Cumulative Disease Damage Among African American Women With Systemic Lupus Erythematosus

Am J Public Health. 2015 Oct;105(10):2099-107. doi: 10.2105/AJPH.2015.302727. Epub 2015 Aug 13.

Abstract

Objectives: We examined associations between unfair treatment, attributions of unfair treatment to racial discrimination, and cumulative disease damage among African American women with systemic lupus erythematosus (SLE).

Methods: We used multivariable regression models to examine SLE damage among 578 African American women in metropolitan Atlanta, Georgia, recruited to the Georgians Organized Against Lupus cohort.

Results: When we controlled for demographic, socioeconomic, and health-related covariates, reporting any unfair treatment was associated with greater SLE damage compared with reporting no unfair treatment (b = 0.55; 95% confidence interval = 0.14, 0.97). In general, unfair treatment attributed to nonracial factors was more strongly associated with SLE damage than was unfair treatment attributed to racial discrimination, although the difference was not statistically significant.

Conclusions: Unfair treatment may contribute to worse disease outcomes among African American women with SLE. Unfair treatment attributed to nonracial causes may have a more pronounced negative effect on SLE damage. Future research may further examine possible differences in the effect of unfair treatment by attribution.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Black or African American / psychology*
  • Female
  • Georgia
  • Humans
  • Lupus Erythematosus, Systemic / ethnology*
  • Lupus Erythematosus, Systemic / psychology*
  • Middle Aged
  • Prejudice*
  • Registries
  • Risk Factors
  • Surveys and Questionnaires